Redeye: Verisec - Good momentum

The report for the third quarter of 2018 was in line with our expectations and showed no surprises. The core business had yet a stable quarter and net sales YTD (Q3’18) amounts to SEK 56.7, an increase of ~26 percent y/y. Freja eID continues to enter agreements/partnerships at a high rate, among others; with ATG and one of Sweden’s largest pharmacy. Following the report, we only make minor estimate changes with no effect on the valuation.

Read more and download the research update: http://bit.ly/2P2cm88

Become a member at Redeye to access the latest research on Life Science and Tech companies.

This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/about/